Future research should delve deeper into the specific mechanisms of ANGPTL4 in RCC and validate its application value through larger clinical samples and comprehensive in vitro and in vivo experiments, providing new insights and methods for the early diagnosis and treatment of RCC. This evidence concerns the gene ANGPTL4 and renal cell carcinoma.